Lifeboat Foundation

That all sounds great. And software is supposed to improve every industry. But when it comes to health care, it leaves one important question unanswered: Why aren’t we getting any healthier?

Venture investors are chasing breakout successes in digital health, but those investment dollars aren’t making people healthier.

• Genetic testing will be a cornerstone of healthcare in 2019, experts say.
• There are two ways to do the testing: getting a costly but complete genetic workup through a doctor or opting for a cheaper at-home test like those sold by 23andMe.
• Clinicians and advocates criticize the at-home approach, which they say prioritizes convenience over privacy and long-term health.
• But entrepreneurs counter that the at-home approach lets more people access information.
• Which method will win out, and at what cost?

As millions of Americans sat down to Thanksgiving dinner, the biomedical researcher James Hazel sent out a stark warning about the genetic-testing kits that he surmised would be a hot topic of conversation.

Most of them are neither safe nor private.

• A group of hospitals have built a nonprofit generic drugmaker called Civica Rx.
• On Monday, another 12 health systems joined the organization.
• The hope is to make generic drugs that are in shortage or have artificially high prices based on what hospitals need.

Hospitals have a creative plan to tackle the high price and frequent shortages of generic drugs.

The nonprofit company, dubbed Civica Rx, was first announced in early 2018, and has gained a lot of attention from other hospitals around the US who are interested in being a part of the venture.

In recent years, antibiotic-resistant bacteria has become such a concern that the World Health Organization has cautioned of a “post-antibiotic era,” which may be here soon. According to the CDC, in America alone around 2 million people are infected with antibiotic-resistant infections annually and in less developed countries it is quickly becoming one of the greatest concerns in public health.

In an urgent search for new natural antibiotics, scientists are examining ancient remedies in order to determine what made them effective. One such remedy comes from the Boho Highlands of Northern Ireland, where ancient Irish Druids utilized natural antibiotics from the soil. Inverse reports the findings of these scientists, published in Frontiers in Microbiology:

[The] alkaline soil sampled from the Sacred Heart Church in the town of Toneel North contains a new strain of bacteria they named Streptomyches sp. myrophorea. Testing revealed that this strain inhibited the growth of four of the six multi-resistant pathogens identified by the WHO as “high priority pathogens.”

Continue reading “Amid antibiotic failures, scientists search for answers in ancient remedies” »

A stroke or a “brain attack” can have life-threatening consequences just like a heart attack. However, there are some early signs of a stroke that start showing up as early as a month before it actually happens. Here are seven such symptoms—knowing them might save someone’s life.

Strokes happen when a blood vessel transporting oxygen to the brain bursts or gets obstructed by a clot. As a result, the brain doesn’t receive much oxygen and the brain cells start to die off. The functions controlled by the affected part of the brain will not be performed normally, and this will have a huge impact on health.

A stroke can manifest differently in every individual, but one thing in common is that it initiates suddenly. Read below the most common symptoms that manifest one month before a stroke, and if you are experiencing any of these, think about consulting your doctor.

Continue reading “7 Early Warning Signs of ‘Brain Attack’ That Appear Almost 1 Month Before Stroke” »

New UC Berkeley study suggests that AI makes it easy to mine mobile phones and fitness trackers for health information, even data the user has deleted.

Power suits, robotaxis, Leonardo da Vinci mania—just a few of the things to look out for in 2019. But what else will make our top ten stories for the year ahead?

Click here to subscribe to The Economist on YouTube: https://econ.st/2xvTKdy

Continue reading “What will be the biggest stories of 2019? | Part One | The Economist” »

In 2016, a mysterious illness spread inside the National Institutes of Health’s Clinical Center, the U.S. government’s most prominent research hospital, in Bethesda, Maryland. Patients were somehow being sickened by an antibiotic-resistant strain of bacteria that practically never causes disease in humans. Two years later, a new study seems to finally have confirmed where this bug likely came from: the hospital’s own plumbing.

During a six-month period in 2016, six patients came down with infections caused by Sphingomonas bacteria. Four of the patients had an antibiotic-resistant strain of a particular species, Sphingomonas koreensis, which was first discovered in some of Korea’s natural mineral water spots in the early 2000s.

Thanks to Authority Magazine and Fotis Georgiadis for the interview — Bioquark inc. (http://www.bioquark.com) — Regeneration, Disease Reversion, Age Rejuvenation — https://medium.com/authority-magazine/the-future-is-now-we-a…cc6dc8ebf1